Many drug-adapted neuroblastoma cell lines display enhanced ABCB1 activity [27,35], and drug-adapted cell lines have been shown to reflect clinically relevant resistance mechanisms [26,36,37,38,39,40,41,42,43,44,45]. Here, ABCB1 is linked to neuroblastoma.